{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:14:00Z","timestamp":1789582440129,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13555-021-00524-w","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T20:03:09Z","timestamp":1618257789000},"page":"719-732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-9720","authenticated-orcid":false,"given":"Chang-Yu","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1474","authenticated-orcid":false,"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"524_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40348-015-0027-1","volume":"2","author":"M Albrecht","year":"2015","unstructured":"Albrecht M, Dittrich AM. Expression and function of histamine and its receptors in atopic dermatitis. Mol Cell Pediatr. 2015;2:1\u20138. https:\/\/doi.org\/10.1186\/s40348-015-0027-1.","journal-title":"Mol Cell Pediatr"},{"key":"524_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1590\/S1517-83822011000300018","volume":"42","author":"MA El-Nakeeb","year":"2011","unstructured":"El-Nakeeb MA, Abou-Shleib HM, Khalil AM, Omar HG, El-Halfawy OM. In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates. Braz J Microbiol. 2011;42:980\u201391.","journal-title":"Braz J Microbiol"},{"key":"524_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9030107","volume":"9","author":"M Lagadinou","year":"2020","unstructured":"Lagadinou M, Onisor MO, Rigas A, Musetescu DV, Gkentzi D, Assimakopoulos SF, et\u00a0al. Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance. Antibiotics. 2020;9:1\u201312.","journal-title":"Antibiotics"},{"key":"524_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/jac\/dkr154","volume":"66","author":"S Chopra","year":"2011","unstructured":"Chopra S, Matsuyama K, Hutson C, Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother. 2011;66:1533\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"524_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2230.2005.01721.x","volume":"30","author":"Q Xia","year":"2005","unstructured":"Xia Q, Yang S, Zhang SQ, Chen B, Wang DB, Zhu QX, et\u00a0al. The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-\u03b1 and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine. Clin Exp Dermatol. 2005;30:165\u201370.","journal-title":"Clin Exp Dermatol"},{"key":"524_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.bjp.0706112","volume":"145","author":"A Russo","year":"2005","unstructured":"Russo A, Russo G, Peticca M, Pietropaolo C, Di Rosa M, Iuvone T. Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol. 2005;145:24\u201333.","journal-title":"Br J Pharmacol"},{"key":"524_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/CAD.0000000000000670","volume":"29","author":"ID Ionov","year":"2018","unstructured":"Ionov ID, Gorev NP, Roslavtseva LA, Frenkel DD. Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a) anthracene-treated rats. Anticancer Drugs. 2018;29:956\u201364.","journal-title":"Anticancer Drugs"},{"key":"524_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharep.2016.11.006","volume":"69","author":"M Wolak","year":"2017","unstructured":"Wolak M, Bojanowska E, Staszewska T, Ciosek J, Juszczak M, Drobnik J. The role of histamine in the regulation of the viability, proliferation and transforming growth factor \u03b21 secretion of rat wound fibroblasts. Pharmacol Rep. 2017;69:314\u201321. https:\/\/doi.org\/10.1016\/j.pharep.2016.11.006.","journal-title":"Pharmacol Rep"},{"key":"524_CR9","first-page":"245","volume":"18","author":"H Murota","year":"2008","unstructured":"Murota H, Bae S, Hamasaki Y, Maruyama R, Katayama I. Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts. J Investig Allergol Clin Immunol. 2008;18:245\u201352.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"524_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00006534-198108000-00018","volume":"68","author":"BM Topol","year":"1981","unstructured":"Topol BM, Lewis VLJ, Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar, and keloid. Plast Reconstr Surg. 1981;68:227\u201332.","journal-title":"Plast Reconstr Surg"},{"key":"524_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0021-5198(19)32429-1","volume":"60","author":"H Suzawa","year":"1992","unstructured":"Suzawa H, Kikuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol. 1992;60:91\u20136.","journal-title":"Jpn J Pharmacol"},{"key":"524_CR12","doi-asserted-by":"publisher","unstructured":"Penicheid AG, Osorio EY, Melby PC, Travi BL. Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous leishmania major infection. PLoS Negl Trop Dis. 2020;14:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0008482.","DOI":"10.1371\/journal.pntd.0008482"},{"key":"524_CR13","doi-asserted-by":"publisher","unstructured":"de Melo Mendes V, Tempone AG, Treiger Borborema SE. Antileishmanial activity of H1-antihistamine drugs and cellular alterations in Leishmania (L.) infantum. Acta Trop. 2019;195:6\u201314. https:\/\/doi.org\/10.1016\/j.actatropica.2019.04.017.","DOI":"10.1016\/j.actatropica.2019.04.017"},{"key":"524_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1365-2222.1999.00009.x-i1","volume":"29","author":"MK Church","year":"1999","unstructured":"Church MK. Non-H1-receptor effects of antihistamines. Clin Exp Allergy. 1999;29:39\u201348.","journal-title":"Clin Exp Allergy"},{"key":"524_CR15","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.2174\/138161208786369777","volume":"14","author":"G Vena","year":"2008","unstructured":"Vena G, Cassano N, Buquicchio R, Ventura M. Antiinflammatory effects of H1-antihistamines: clinical and immunological relevance. Curr Pharm Des. 2008;14:2902\u201311.","journal-title":"Curr Pharm Des"},{"key":"524_CR16","first-page":"495","volume":"8","author":"W B\u00e4umer","year":"2010","unstructured":"B\u00e4umer W, Ro\u00dfbach K. Histamin als Immunmodulator. J Ger Soc Dermatol. 2010;8:495\u2013504.","journal-title":"J Ger Soc Dermatol"},{"key":"524_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2222.1998.00206.x","volume":"28","author":"C Albanesi","year":"1998","unstructured":"Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy. 1998;28:101\u20139.","journal-title":"Clin Exp Allergy"},{"key":"524_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000093709","volume":"140","author":"C Traidl-Hoffmann","year":"2006","unstructured":"Traidl-Hoffmann C, M\u00fcnster I, Ring J, Behrendt H. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: implications for anti-inflammatory activity of antihistamines. Int Arch Allergy Immunol. 2006;140:315\u201320.","journal-title":"Int Arch Allergy Immunol"},{"key":"524_CR19","first-page":"1629","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Caraffa A, Tet\u00e8 G, Gallenga CE, Ross R, Kritas SK, et\u00a0al. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J Biol Regul Homeost Agents Italy. 2020;34:1629\u201332.","journal-title":"J Biol Regul Homeost Agents Italy"},{"key":"524_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2222.2005.0078.x","volume":"5","author":"GM Walsh","year":"2005","unstructured":"Walsh GM. Anti-inflammatory properties of antihistamines: an update. Clin Exp Allergy Rev. 2005;5:21\u20135.","journal-title":"Clin Exp Allergy Rev"},{"key":"524_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1008156","volume":"15","author":"J Chen","year":"2019","unstructured":"Chen J, Dai L, Goldstein A, Zhang H, Tang W, Craig Forrest J, et\u00a0al. Identification of new antiviral agents against Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation. PLoS Pathog. 2019;15:1\u201325.","journal-title":"PLoS Pathog"},{"key":"524_CR22","first-page":"36","volume":"107","author":"TR Hall","year":"1984","unstructured":"Hall TR, Harvey S, Chadwick A. Prolactin and growth hormone secretion in chickens: stimulation by histamine and inhibition by gamma-aminobutyric acid. Acta Endocrinol. 1984;107:36\u201341.","journal-title":"Acta Endocrinol"},{"key":"524_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1515\/JPEM.2009.22.5.425","volume":"22","author":"P Mahachoklertwattana","year":"2009","unstructured":"Mahachoklertwattana P, Wanasuwankul S, Poomthavorn P, Choubtum L, Sriphrapradang A. Short-term cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor-I. J Pediatr Endocrinol Metab. 2009;22:425\u201332.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"524_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2007-1004905","volume":"22","author":"RH Rosskamp","year":"1990","unstructured":"Rosskamp RH, Haverkamp F, von Kalckreuth G. The effect of cyproheptadine on plasma growth hormone (GH) and on somatostatin response to GH-releasing hormone in man. Horm Metab Res. 1990;22:295\u20137.","journal-title":"Horm Metab Res"},{"key":"524_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1507\/endocrj1954.36.429","volume":"36","author":"K Hanew","year":"1989","unstructured":"Hanew K, Sugawara A, Shimizu Y, Sato S, Sasaki A, Tazawa S, et\u00a0al. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly. Endocrinol Jpn. 1989;36:429\u201338.","journal-title":"Endocrinol Jpn"},{"key":"524_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/sj.jid.5701160","volume":"128","author":"E Pelle","year":"2008","unstructured":"Pelle E, McCarthy J, Seltmann H, Huang X, Mammone T, Zouboulis CC, et\u00a0al. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J Invest Dermatol. 2008;128:1280\u20135.","journal-title":"J Invest Dermatol"},{"key":"524_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pain.2009.03.001","volume":"144","author":"P Sikand","year":"2009","unstructured":"Sikand P, Shimada SG, Green BG, LaMotte RH. Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage. Pain. 2009;144:66\u201375. https:\/\/doi.org\/10.1016\/j.pain.2009.03.001.","journal-title":"Pain"},{"key":"524_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0014-2999(00)00060-1","volume":"391","author":"JI Mobarakeh","year":"2000","unstructured":"Mobarakeh JI, Sakurada S, Katsuyama S, Kutsuwa M, Kuramasu A, Lin ZY, et\u00a0al. Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol. 2000;391:81\u20139.","journal-title":"Eur J Pharmacol"},{"key":"524_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejphar.2018.07.011","volume":"834","author":"E Khalilzadeh","year":"2018","unstructured":"Khalilzadeh E, Azarpey F, Hazrati R, Vafaei SG. Evaluation of different classes of histamine H1 and H2 receptor antagonist effects on neuropathic nociceptive behavior following tibial nerve transection in rats. Eur J Pharmacol. 2018;834:221\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.011.","journal-title":"Eur J Pharmacol."},{"key":"524_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/039463200501800421","volume":"18","author":"L Logothetis","year":"2005","unstructured":"Logothetis L, Mylonas IA, Baloyannis S, Pashalidou M, Orologas A, Zafeiropoulos A, et\u00a0al. A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int J Immunopathol Pharmacol. 2005;18:771\u20138.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"524_CR31","doi-asserted-by":"publisher","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","volume":"9","author":"M Bertolini","year":"2014","unstructured":"Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et\u00a0al. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS ONE. 2014;9:e94260. https:\/\/doi.org\/10.1371\/journal.pone.0094260.","journal-title":"PLoS ONE"},{"key":"524_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jdermsci.2013.04.029","volume":"72","author":"T Ito","year":"2013","unstructured":"Ito T, Fujiyama T, Hashizume H, Tokura Y. Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata. J Dermatol Sci. 2013;72:68\u201371.","journal-title":"J Dermatol Sci"},{"key":"524_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1346-8138.2006.00017.x","volume":"33","author":"K Katagiri","year":"2006","unstructured":"Katagiri K, Arakawa S, Hatano Y, Fujiwara S. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. J Dermatol. 2006;33:75\u20139.","journal-title":"J Dermatol"},{"key":"524_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jdermsci.2010.03.009","volume":"58","author":"M Ohyama","year":"2010","unstructured":"Ohyama M, Shimizu A, Tanaka K, Amagai M. Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. J Dermatol Sci. 2010;58:154\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.03.009.","journal-title":"J Dermatol Sci"},{"key":"524_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1346-8138.2009.00647.x","volume":"36","author":"S Inui","year":"2009","unstructured":"Inui S, Nakajima T, Toda N, Itami S. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: retrospective analysis of 121 cases. J Dermatol. 2009;36:323\u20137.","journal-title":"J Dermatol"},{"key":"524_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.1026","author":"YB Lee","year":"2020","unstructured":"Lee YB, Lee W-S. Efficacy of antihistamines in combination with topical corticosteroid and superficial cryotherapy for treatment of alopecia areata: a retrospective cohort study. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1026.","journal-title":"J Am Acad Dermatol."},{"key":"524_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/scitranslmed.3003122","volume":"4","author":"LA Garza","year":"2012","unstructured":"Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, et\u00a0al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med. 2012;4:126\u201334.","journal-title":"Sci Transl Med."},{"key":"524_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0091-6749(89)90104-8","volume":"83","author":"EN Charlesworth","year":"1989","unstructured":"Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol. 1989;83:905\u201312.","journal-title":"J Allergy Clin Immunol"},{"key":"524_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/09546634.2017.1341610","volume":"29","author":"A Rossi","year":"2018","unstructured":"Rossi A, Campo D, Fortuna MC, Garelli V, Pranteda G, De Vita G, et\u00a0al. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. J Dermatolog Treat. 2018;29:149\u201351. https:\/\/doi.org\/10.1080\/09546634.2017.1341610.","journal-title":"J Dermatolog Treat"},{"key":"524_CR40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/jdv.12403","volume":"28","author":"HE Lee","year":"2014","unstructured":"Lee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, et\u00a0al. Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study. J Eur Acad Dermatol Venereol. 2014;28:1654\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"524_CR41","first-page":"14","volume":"17","author":"D Pandey","year":"2019","unstructured":"Pandey D, Agrawal S. Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne: a randomised control trial. Kathmandu Univ Med J. 2019;17:14\u20139.","journal-title":"Kathmandu Univ Med J"},{"key":"524_CR42","first-page":"213","volume":"18","author":"JF Wang","year":"2019","unstructured":"Wang JF, Lederhandler MH, Brinster N, Soter NA, Ba JFW, Lederhandler MH, et\u00a0al. Vesiculobullous Darier disease symptomatically responsive to cetirizine. J Drugs Dermatol. 2019;18:213\u20134.","journal-title":"J Drugs Dermatol"},{"key":"524_CR43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0190-9622(87)70251-5","volume":"17","author":"V Falanga","year":"1987","unstructured":"Falanga V, Medsger TAJ. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol. 1987;17:648\u201356.","journal-title":"J Am Acad Dermatol"},{"key":"524_CR44","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2796.1992.tb00974.x","volume":"231","author":"DW Ching","year":"1992","unstructured":"Ching DW, Leibowitz MR. Ketotifen\u2014a therapeutic agent of eosinophilic fasciitis? J Intern Med. 1992;231:555\u20139.","journal-title":"J Intern Med"},{"key":"524_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00431-001-0871-y","volume":"161","author":"A U\u00e7kun","year":"2002","unstructured":"U\u00e7kun A, Sipahi T, Akg\u00fcn D, Oksal A. Eosinophilic fasciitis successfully treated with oral hydroxyzine: a new therapeutic use of an old drug? Eur J Pediatr. 2002;161:118\u20139.","journal-title":"Eur J Pediatr"},{"key":"524_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3904\/kjim.2005.20.2.180","volume":"20","author":"JW Hur","year":"2005","unstructured":"Hur JW, Lee HS, Uhm WS, Jun JB, Bae SC, Park CK, et\u00a0al. Eosinophilic fasciitis associated with autoimmune thyroiditis. Korean J Intern Med. 2005;20:180\u20132.","journal-title":"Korean J Intern Med"},{"key":"524_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1365-2133.1992.tb00687.x","volume":"126","author":"DWS Harris","year":"1992","unstructured":"Harris DWS, Ostelere L, Buckley C, Johnson M, Rustin MHA. Eosinophilic pustular folliculitis in an HIV-positive man: response to cetirizine. Br J Dermatol. 1992;126:392\u20134.","journal-title":"Br J Dermatol"},{"key":"524_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1695-4033(01)77652-7","volume":"55","author":"J Luelmo Aguilar","year":"2001","unstructured":"Luelmo Aguilar J, S\u00e1ez AA. Eosinophilic pustular folliculitis in childhood. An Esp Pediatr. 2001;55:154\u20138.","journal-title":"An Esp Pediatr"},{"key":"524_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/archderm.1991.01680020074008","volume":"127","author":"D Rosenthal","year":"1991","unstructured":"Rosenthal D, LeBoit PE, Klumpp L, Berger TG. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol. 1991;127:206\u20139.","journal-title":"Arch Dermatol"},{"key":"524_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/pde.13764","volume":"36","author":"E Odyakmaz Demirsoy","year":"2019","unstructured":"Odyakmaz Demirsoy E, Demirsoy U, Ozod U, Kiran R. Eosinophilic pustular folliculitis of infancy suppressed with cetirizine. Pediatr Dermatol. 2019;36:395\u20136.","journal-title":"Pediatr Dermatol"},{"key":"524_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/00128071-200405030-00007","volume":"5","author":"E Ellis","year":"2004","unstructured":"Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol. 2004;5:189\u201397.","journal-title":"Am J Clin Dermatol"},{"key":"524_CR52","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/jdv.13706","volume":"30","author":"F R\u00e4\u00dfler","year":"2016","unstructured":"R\u00e4\u00dfler F, Luk\u00e1cs J, Elsner P. Treatment of eosinophilic cellulitis (Wells syndrome)\u2014a systematic review. J Eur Acad Dermatol Venereol. 2016;30:1465\u201379.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"524_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/229255031202000204","volume":"20","author":"H Sinno","year":"2012","unstructured":"Sinno H, Lacroix JP, Lee J, Izadpanah A, Borsuk R, Watters K, et\u00a0al. Diagnosis and management of eosinophilic cellulitis (Wells\u2019 syndrome): a case series and literature review. Can J Plast Surg. 2012;20:91\u20137.","journal-title":"Can J Plast Surg"},{"key":"524_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/000155599750010841","volume":"79","author":"K Aroni","year":"1999","unstructured":"Aroni K, Aivaliotis M, Liossi A, Davaris P. Eosinophilic cellulitis in a child successfully treated with cetirizine. Acta Derm Venereol. 1999;79:332.","journal-title":"Acta Derm Venereol"},{"key":"524_CR55","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1346-8138.2002.tb00211.x","volume":"29","author":"F Miyagawa","year":"2002","unstructured":"Miyagawa F, Danno K, Uehara M. Erythema gyratum repens responding to cetirizine hydrochloride. J Dermatol. 2002;29:731\u20134. https:\/\/doi.org\/10.1111\/j.1346-8138.2002.tb00211.x.","journal-title":"J Dermatol"},{"key":"524_CR56","first-page":"777","volume":"122","author":"MH Guillet","year":"1995","unstructured":"Guillet MH, Le Noach E, Milochau P, Sassolas B, Guillet G. Familial erythermalgia treated with pizotifen. Ann Dermatol Venereol. 1995;122:777\u20139.","journal-title":"Ann Dermatol Venereol"},{"key":"524_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0165-1838(95)00121-2","volume":"58","author":"R Sakakibara","year":"1996","unstructured":"Sakakibara R, Fukutake T, Kita K, Hattori T. Treatment of primary erythromelalgia with cyproheptadine. J Auton Nerv Syst. 1996;58:121\u20132.","journal-title":"J Auton Nerv Syst"},{"key":"524_CR58","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2147\/JPR.S154462","volume":"11","author":"SW Tham","year":"2018","unstructured":"Tham SW, Giles M. Current pain management strategies for patients with erythromelalgia: a critical review. J Pain Res. 2018;11:1689\u201398.","journal-title":"J Pain Res"},{"key":"524_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-1947-8-69","volume":"8","author":"SM Al-Minshawy","year":"2014","unstructured":"Al-Minshawy SM, El-Mazary AAM. An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature. J Med Case Rep. 2014;8:1\u20136.","journal-title":"J Med Case Rep"},{"key":"524_CR60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0021-8707(63)90028-5","volume":"34","author":"D Abramson","year":"1963","unstructured":"Abramson D, Tuck S, Chu LDT. Vascular effects of chlorpheniramine maleate. J Allergy. 1963;34:258\u201369.","journal-title":"J Allergy"},{"key":"524_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1346-8138.2000.tb02131.x","volume":"27","author":"TY Yoon","year":"2000","unstructured":"Yoon TY, Ahn GB, Chang SH. Complete remission of hypereosinophilic syndrome after interferon-\u03b1 therapy: report of a case and literature review. J Dermatol. 2000;27:110\u20135.","journal-title":"J Dermatol"},{"key":"524_CR62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/ced.13808","volume":"44","author":"K Sugita","year":"2019","unstructured":"Sugita K, Yamamoto O. Hypereosinophilia successfully treated with the novel antihistamine bilastine. Clin Exp Dermatol. 2019;44:586\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"524_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00126839-200607040-00002","volume":"7","author":"R Corc\u00f3stegui","year":"2006","unstructured":"Corc\u00f3stegui R, Labeaga L, Inner\u00e1rity A, Berisa A, Orjales A. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Drugs R&D. 2006;7:219\u201331.","journal-title":"Drugs R&D"},{"key":"524_CR64","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1158\/1078-0432.CCR-18-0873","volume":"24","author":"LW Ayers","year":"2018","unstructured":"Ayers LW, Barbachano-Guerrero A, McAllister SC, Ritchie JA, Asiago-Reddy E, Bartlett LC, et\u00a0al. Mast cell activation and KSHV infection in Kaposi sarcoma. Clin Cancer Res. 2018;24:5085\u201397.","journal-title":"Clin Cancer Res"},{"key":"524_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00105-017-4100-7","volume":"69","author":"I Stolze","year":"2018","unstructured":"Stolze I, Hamm H. Lichen nitidus and lichen striatus. Hautarzt. 2018;69:121\u20136.","journal-title":"Hautarzt"},{"key":"524_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0190-9622(08)81081-X","volume":"23","author":"RY Vaughn","year":"1990","unstructured":"Vaughn RY, Smith JG. The treatment of lichen nitidus with astemizole. J Am Acad Dermatol. 1990;23:757\u20138. https:\/\/doi.org\/10.1016\/S0190-9622(08)81081-X.","journal-title":"J Am Acad Dermatol."},{"key":"524_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-4362.1989.tb01313.x","volume":"28","author":"J Ocampo","year":"1989","unstructured":"Ocampo J, Torn\u00c9 R. Generalized lichen nitidus: report of two cases treated with astemizol. Int J Dermatol. 1989;28:49\u201351.","journal-title":"Int J Dermatol"},{"key":"524_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1346-8138.2011.01205.x","volume":"39","author":"F Gao","year":"2012","unstructured":"Gao F, Miyamoto M, Ogata H, Tsuboi R, Mitsuhashi Y. Generalized lichen nitidus in a Japanese girl. J Dermatol. 2012;39:185\u20137.","journal-title":"J Dermatol"},{"key":"524_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1525-1470.2005.22215.x","volume":"22","author":"N Al-Mutairi","year":"2005","unstructured":"Al-Mutairi N, Hassanein A, Nour-Eldin O, Arun J. Generalized lichen nitidus. Pediatr Dermatol. 2005;22:158\u201360.","journal-title":"Pediatr Dermatol"},{"key":"524_CR70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1529-8019.2010.01359.x","volume":"23","author":"R D\u2019Ovidio","year":"2010","unstructured":"D\u2019Ovidio R, Rossi A, Di Prima TM. Effectiveness of the association of cetirizine and topical steroids in lichen planus pilaris\u2014an open-label clinical trial. Dermatol Ther. 2010;23:547\u201352.","journal-title":"Dermatol Ther"},{"key":"524_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/ced.13203","volume":"42","author":"F Mardones","year":"2017","unstructured":"Mardones F, Shapiro J. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience. Clin Exp Dermatol. 2017;42:755\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"524_CR72","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijwd.2018.11.003","volume":"5","author":"S Tavakolpour","year":"2019","unstructured":"Tavakolpour S, Mahmoudi HR, Abedini R, Kamyab Hesari K, Kiani A, Daneshpazhooh M. Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment. Int J Women\u2019s Dermatol. 2019;5:116\u201323. https:\/\/doi.org\/10.1016\/j.ijwd.2018.11.003.","journal-title":"Int J Women\u2019s Dermatol"},{"key":"524_CR73","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2133.1982.tb11685.x","volume":"106","author":"R Greenwood","year":"1982","unstructured":"Greenwood R, Tring FC. Treatment of malignant acanthosis Nigricans with cyproheptadine. Br J Dermatol. 1982;106:697\u20138.","journal-title":"Br J Dermatol"},{"key":"524_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4419-9533-9_3","volume":"716","author":"J-I Kashiwakura","year":"2011","unstructured":"Kashiwakura J-I, Otani IM, Kawakami T. Monomeric IgE and mast cell development, survival and function. Adv Exp Med Biol. 2011;716:29\u201346.","journal-title":"Adv Exp Med Biol"},{"key":"524_CR75","unstructured":"Medina V, Martinel D, Brenzoni P, Massari N, Carabajal E, Rivera E, et\u00a0al. Histamine receptors as potential therapeutic targets for cancer drug development. Drug Dev Case Study Based Insight Mod Strateg. 2011:75\u2013100."},{"key":"524_CR76","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.3892\/or.2016.5201","volume":"36","author":"CHR Or","year":"2016","unstructured":"Or CHR, Su HL, Lee WC, Yang SY, Ho C, Chang CC. Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3\/MCL-1 survival signaling and retards B16\u2013F10 melanoma growth in vivo. Oncol Rep. 2016;36:3465\u201371.","journal-title":"Oncol Rep"},{"key":"524_CR77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/all.14273","volume":"75","author":"I Fritz","year":"2020","unstructured":"Fritz I, Wagner P, Bottai M, Eriksson H, Ingvar C, Krakowski I, et\u00a0al. Desloratadine and loratadine use associated with improved melanoma survival. Allergy Eur J Allergy Clin Immunol. 2020;75:7\u201310.","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"524_CR78","first-page":"1","volume":"25","author":"E Pestelli","year":"2003","unstructured":"Pestelli E, Floriani I, Fabbri P, Caproni M. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients. Int J Tissue React. 2003;25:1\u20138.","journal-title":"Int J Tissue React"},{"key":"524_CR79","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-4362.1995.tb00630.x","volume":"34","author":"M Capponi","year":"1995","unstructured":"Capponi M, Maria Palleschi G, Falcos D, Papi C, Lotti T. Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions. Int J Dermatol. 1995;34:510\u20133.","journal-title":"Int J Dermatol"},{"key":"524_CR80","first-page":"97","volume":"23","author":"E Pestelli","year":"2001","unstructured":"Pestelli E, Caproni M, Giomi B, Volpi W, Spallanzani A, Cardinali C, et\u00a0al. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study. Int J Tissue React. 2001;23:97\u2013103.","journal-title":"Int J Tissue React"},{"key":"524_CR81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1254\/jphs.SC0070127","volume":"104","author":"S Moriyasu","year":"2007","unstructured":"Moriyasu S, Yamamoto K, Kureyama N, Okamura K, Ikeda T, Yamatodani A. Involvement of histamine released from mast cells in acute radiation dermatitis in mice. J Pharmacol Sci. 2007;104:187\u201390.","journal-title":"J Pharmacol Sci"},{"key":"524_CR82","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0360-3016(96)00621-9","volume":"37","author":"R Murakami","year":"1997","unstructured":"Murakami R, Baba Y, Nishimura R, Furusawa M, Yokoyama T, Yamashita Y, et\u00a0al. The effect of azelastine on acute radiation dermatitis in mice models. Int J Radiat Oncol Biol Phys. 1997;37:907\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"524_CR83","first-page":"151","volume":"14","author":"M Furusawa","year":"1996","unstructured":"Furusawa M, Baba Y, Murakami R, Yokoyama T, Uozumi H, Nishimura R, et\u00a0al. Azelastine: its clinical application for radiation dermatitis. Radiat Med. 1996;14:151\u20134.","journal-title":"Radiat Med"},{"key":"524_CR84","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/1346-8138.14901","volume":"46","author":"M Kinoshita-Ise","year":"2019","unstructured":"Kinoshita-Ise M, Shear NH. Diagnostic and therapeutic approach to scalp dysesthesia: a case series and published work review. J Dermatol. 2019;46:526\u201330.","journal-title":"J Dermatol"},{"key":"524_CR85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archderm.134.3.327","volume":"134","author":"D Hoss","year":"1998","unstructured":"Hoss D, Segal S. Scalp dysesthesia. Arch Dermatol. 1998;134:327\u201330.","journal-title":"Arch Dermatol"},{"key":"524_CR86","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.pain.2011.06.001","volume":"152","author":"P Sikand","year":"2011","unstructured":"Sikand P, Shimada SG, Green BG, Lamotte RH. Sensory responses to injection and punctate application of capsaicin and histamine to the skin. Pain. 2011;152:2485\u201394.","journal-title":"Pain"},{"key":"524_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.dsi.2012.06.002","volume":"31","author":"CC Chi","year":"2013","unstructured":"Chi CC. Evidence-based dermatology. Dermatol Sin. 2013;31:2\u20136. https:\/\/doi.org\/10.1016\/j.dsi.2012.06.002.","journal-title":"Dermatol Sin"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00524-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T10:15:05Z","timestamp":1675160105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00524-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"27 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}